Gagante v. Pfizer, Inc.

Filing 6

ORDER TRANSFERRING CASE to the District of South Carolina and assigned to the Honorable Richard M. Gergel. (sp, COURT STAFF) (Filed on 4/21/2014) [Transferred from California Northern on 4/22/2014.]

2:14-mn-02502-RMG Date Filed 04/18/14 Entry Number 87 Page 1 of 3
Case MDL No. 2502 Document 358 Filed 04/18/14 Page 1 of 3
UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

A TRUE COPY
ATTEST: ROBIN L. BLUME, CLERK
BY:
DEPUTY CLERK

IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)

MDL No. 2502

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO −18)

On February 18, 2014, the Panel transferred 42 civil action(s) to the United States District Court for
the District of South Carolina for coordinated or consolidated pretrial proceedings pursuant to 28
U.S.C. §1407. See _F.Supp.2d_ (J.P.M.L. 2014). Since that time, 332 additional action(s) have been
transferred to the District of South Carolina. With the consent of that court, all such actions have
been assigned to the Honorable Richard M Gergel.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the District of South Carolina and assigned to Judge
Gergel.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. §1407 to the
District of South Carolina for the reasons stated in the order of February 18, 2014, and, with the
consent of that court, assigned to the Honorable Richard M Gergel.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the District of South Carolina. The transmittal of this order to said Clerk shall be
stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7−day period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

Jeffery N. Lüthi
Clerk of the Panel

Apr 18, 2014

2:14-mn-02502-RMG Date Filed 04/18/14 Entry Number 87 Page 2 of 3
Case MDL No. 2502 Document 358 Filed 04/18/14 Page 2 of 3

IN RE: LIPITOR (ATORVASTATIN CALCIUM)
MARKETING, SALES PRACTICES AND
PRODUCTS LIABILITY LITIGATION (NO. II)

SCHEDULE CTO−18 − TAG−ALONG ACTIONS

DIST

DIV.

C.A.NO.

CASE CAPTION

CALIFORNIA NORTHERN
CAN

5

14−01484

Gagante v. Pfizer, Inc.

KENTUCKY EASTERN
KYE

5

14−00129

Bryant v. Pfizer, Inc.

KENTUCKY WESTERN
KYW

4

14−00030

Hammack v. Pfizer Inc.

14−00790
14−00860
14−01010
14−01011
14−01185
14−01186
14−01187
14−01244
14−01266
14−01278
14−01281
14−01876
14−01144

COLEMAN v. PFIZER, INC.
COPELAND v. PFIZER, INC.
JONES v. PFIZER, INC.
HILBERT v. PFIZER, INC.
COOPERSTEIN v. PFIZER, INC.
NEVES v. PFIZER, INC.
FAILLA v. PFIZER, INC.
ZAPPARDINO v. PFIZER, INC.
JACKSON v. PFIZER, INC.
PIERSON v. PFIZER, INC.
AHLADIANAKIS v. PFIZER, INC.
DEMMING v. PFIZER, INC.
KROLL v. PFIZER, INC.

14−00114

Honkonen v. Pfizer Inc

NEW JERSEY
NJ
NJ
NJ
NJ
NJ
NJ
NJ
NJ
NJ
NJ
NJ
NJ
NJ

1
1
1
1
1
1
1
1
1
1
1
1
2

OHIO SOUTHERN
OHS

1

PENNSYLVANIA EASTERN
PAE

2

14−01211

HENRY v. PFIZER, INC.

MDL No. 2502

2:14-mn-02502-RMG Date Filed 04/18/14 Entry Number 87 Page 3 of 3
Case MDL No. 2502 Document 358 Filed 04/18/14 Page 3 of 3
PAE
2
14−01212
SMITH v. PFIZER, INC.
PAE
2
14−01213
RICKABAUGH v. PFIZER, INC.
PAE
2
14−01214
TOMLIN v. PFIZER INC.
PAE
2
14−01215
HAND v. PFIZER, INC.
PAE
2
14−01216
FINLEY v. PFIZER, INC.
PAE
2
14−01217
BROWN v. PFIZER, INC.
PAE
2
14−01218
EDDY v. PFIZER, INC.
PAE
2
14−01219
GERBER et al v. PFIZER, INC.
PAE
2
14−01220
BIER et al v. PFIZER, INC.
PAE
2
14−01221
KITER v. PFIZER, INC.
PAE
2
14−01222
STAGE et al v. PFIZER, INC.
PAE
2
14−01223
MARTINO v. PFIZER, INC.
PAE
2
14−01224
HILL v. PFIZER, INC.
PAE
2
14−01225
GEORGESON v. PFIZER, INC.
PAE
2
14−01226
SOULE v. PFIZER, INC.
PAE
2
14−01227
WILLIAMS v. PFIZER, INC.
PAE
2
14−01228
SIMPSON et al v. PFIZER, INC.
PAE
2
14−01229
LEONARD et al v. PFIZER, INC.
PAE
2
14−01230
KATARZYNSKI et al v. PFIZER, INC.
PAE
2
14−01231
GREEN v. PFIZER, INC.
PAE
2
14−01232
OGLINE v. PFIZER, INC.
PAE
2
14−01233
TINSLEY et al v. PFIZER, INC.
PAE
2
14−01234
COLE v. PFIZER, INC.
PAE
2
14−01235
WATKINS et al v. PFIZER, INC.
PAE
2
14−01236
LANG et al v. PFIZER, INC.
PAE
2
14−01237
MURTIFF v. PFIZER, INC.
PAE
2
14−01238
BOSMA v. PFIZER, INC.
PAE
2
14−01239
CLOSE et al v. PFIZER, INC.
PAE
2
14−01240
MILLER et al v. PFIZER, INC.
PAE
2
14−01241
STEVENS v. PFIZER, INC.
PAE
2
14−01242
ZAFFUTO et al v. PFIZER, INC.
PAE
2
14−01243
EVANS v. PFIZER, INC.
PAE
2
14−01244
PUGH et al v. PFIZER, INC.
PAE
2
14−01245
MATHER et al v. PFIZER, INC.
PAE
2
14−01246
REED v. PFIZER, INC.
PAE
2
14−01440
BALENTINE v. PFIZER, INC.
PAE
2
14−01843
PARIS et al v. PFIZER, INC.
PAE
2
14−01844
STEELE et al v. PFIZER, INC.
PAE
2
14−01886
PARKS et al v. PFIZER, INC.
TENNESSEE EASTERN
TNE

1

14−00097

Mayavski v. Pfizer Inc.

TENNESSEE MIDDLE
TNM

3

14−00886

Diaz v. Pfizer, Inc.